NCT00005042 2014-08-29
SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
AIDS Malignancy Consortium
Phase 2 Completed
AIDS Malignancy Consortium
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer